Retrotope's Series B Round

Retrotope raised a round of funding on October 22, 2014. Investors include Life Science Angels.

Retrotope has created a new category of drug platform to preserve and restore mitochondrial health in degenerative diseases. The unique mechanism of Retrotope's platform prevents cellular damage and r…

Articles about Retrotope's Series B Round: